India stands with the international stakeholders to meet healthcare issues, from pandemic preparedness to progress in digital health, stated Union Commerce Minister Piyush Goyal during BioAsia 2025, a world-class life sciences and health-tech conference organised by the Telangana government.

Key Highlights:
India's Contribution to Global Healthcare Innovation

• India exports low-cost generics to more than 200 nations, earning the reputation of the Pharmacy of the World.

• The nation is shifting from volume-based pharma manufacturing to a value-driven model with emphasis on innovation, R&D, and high-value biopharma.

Government Initiatives Enhancing Healthcare Sector

• Production Linked Incentive (PLI) schemes for pharmaceuticals, bulk drugs, and medical devices.

• Genome India Project making India a global leader in genomics and precision medicine.

• Scaling up Jan Aushadhi Kendras, which distribute low-cost medicines to millions.

• Investment in state-of-the-art medical infrastructure to increase accessibility of healthcare.

India's Investment and Growth Opportunities

• Minister Goyal encouraged global investors to take advantage of India's cost benefits, pool of talent, and robust innovation ecosystem.

• Telangana's Vision: Hyderabad to be a world hub for biosciences, biotech, and life sciences with huge investments in R&D, manufacturing, and skill development.

Statements from Officials:
Piyush Goyal, Union Commerce Minister:
"India is undergoing a massive shift from volume to value in pharma led by innovation and high-value biopharma. Our partnership with international stakeholders will speed up healthcare transformation globally."Telangana CM A Revanth Reddy:
"We are determined to make Hyderabad one of the world's biggest biosciences and life sciences ecosystems."With significant policy changes and international partnerships, India is poised to lead the future of healthcare innovations. The PLI schemes, AIIMS expansion, and biopharma developments are likely to make India a leader in global healthcare manufacturing and R&D.